Advertisement

Reactions Weekly

, Volume 1765, Issue 1, pp 19–19 | Cite as

Alectinib

Transformation of lung adenocarcinoma to non-small cell lung cancer following alectinib resistance : case report
Case report
  • 15 Downloads

Reference

  1. Koyama K, et al. Overexpression of CD 133 and BCL-2 in non-small cell lung cancer with neuroendocrine differentiation after transformation in ALK rearrangement-positive adenocarcinoma. Pathology International 69: 294-299, No. 5, May 2019. Available from: URL: http://doi.org/10.1111/pin.12782 -Japan

Copyright information

© Springer International Publishing AG 2019

Personalised recommendations